|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Yoo CH, Noh SH, Shin DW, Choi SH and Min
JS: Recurrence following curative resection for gastric carcinoma.
Br J Surg. 87:236–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jia B, Liu H, Kong Q and Li B: RKIP
expression associated with gastric cancer cell invasion and
metastasis. Tumour Biol. 33:919–925. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Utans U, Quist WC, McManus BM, et al:
Allograft inflammatory factory-1. A cytokine-responsive macrophage
molecule expressed in transplanted human hearts. Transplantation.
61:1387–1392. 1996.
|
|
5
|
Autieri MV, Kelemen S, Thomas BA, Feller
ED, Goldman BI and Eisen HJ: Allograft inflammatory factor-1
expression correlates with cardiac rejection and development of
cardiac allograft vasculopathy. Circulation. 106:2218–2223. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kimura M, Kawahito Y, Obayashi H, et al: A
critical role for allograft inflammatory factor-1 in the
pathogenesis of rheumatoid arthritis. J Immunol. 178:3316–3322.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Orsmark C, Skoog T, Jeskanen L, Kere J and
Saarialho-Kere U: Expression of allograft inflammatory factor-1 in
inflammatory skin disorders. Acta Derm Venereol. 87:223–227.
2007.PubMed/NCBI
|
|
8
|
Del Galdo F, Maul GG, Jiménez SA and
Artlett CM: Expression of allograft inflammatory factor 1 in
tissues from patients with systemic sclerosis and in vitro
differential expression of its isoforms in response to transforming
growth factor β. Arthritis Rheum. 54:2616–2625. 2006.PubMed/NCBI
|
|
9
|
Liu S, Tan WY, Chen QR, et al:
Daintain/AIF-1 promotes breast cancer proliferation via activation
of the NF-κB/cyclin D1 pathway and facilitates tumor growth. Cancer
Sci. 99:952–957. 2008.PubMed/NCBI
|
|
10
|
Li T, Feng Z, Jia S, et al: Daintain/AIF-1
promotes breast cancer cell migration by up-regulated TNF-α via
activate p38 MAPK signaling pathway. Breast Cancer Res Treat.
131:891–898. 2012.PubMed/NCBI
|
|
11
|
Jia J, Bai Y, Fu K, Sun ZJ, Chen XM and
Zhao YF: Expression of allograft inflammatory factor-1 and CD68 in
haemangioma: implication in the progression of haemangioma. Br J
Dermatol. 159:811–819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lauren P: The two histological main types
of gastric carcinoma: diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
13
|
Aiko T and Sasako M: The new Japanese
classification of gastric carcinoma: points to be revised. Gastric
Cancer. 1:25–30. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang S, Wu X, Chen Y, et al: Prognostic
and predictive role of JWA and XRCC1 expressions in gastric cancer.
Clin Cancer Res. 18:2987–2996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weichert W, Röske A, Gekeler V, et al:
Association of patterns of class I histone deacetylase expression
with patient prognosis in gastric cancer: a retrospective analysis.
Lancet Oncol. 9:139–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takasu S, Tsukamoto T, Cao XY, et al:
Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1
expression and β-catenin activation in gastric carcinogenesis in
N-methyl-N-nitrosourea-treated K19-C2mE transgenic
mice. Cancer Sci. 99:2356–2364. 2008.
|
|
17
|
Iris FJ, Bougueleret L, Prieur S, et al:
Dense Alu clustering and a potential new member of the
NFκB family within a 90 kilobase HLA class III segment. Nat
Genet. 3:137–145. 1993.
|
|
18
|
Autieri MV, Kelemen SE and Wendt KW: AIF-1
is an actin-polymerizing and Rac1-activating protein that promotes
vascular smooth muscle cell migration. Circ Res. 92:1107–1114.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hugo HJ, Wafai R, Blick T, Thompson EW and
Newgreen DF: Staurosporine augments EGF-mediated EMT in PMC42-LA
cells through actin depolymerisation, focal contact size reduction
and Snail1 induction - a model for cross-modulation. BMC Cancer.
9:2352009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song JY, Bae HS, Koo do H, et al:
Candidates for tumor markers of cervical cancer discovered by
proteomic analysis. J Korean Med Sci. 27:1479–1485. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ozawa M, Ringwald M and Kemler R:
Uvomorulin-catenin complex formation is regulated by a specific
domain in the cytoplasmic region of the cell adhesion molecule.
Proc Natl Acad Sci USA. 87:4246–4250. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Conacci-Sorrell M, Simcha I, Ben-Yedidia
T, Blechman J, Savagner P and Ben-Ze’ev A: Autoregulation of
E-cadherin expression by cadherin-cadherin interactions: the roles
of β-catenin signaling, Slug, and MAPK. J Cell Biol. 163:847–857.
2003.PubMed/NCBI
|
|
23
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kanwar SS, Yu Y, Nautiyal J, Patel BB and
Majumdar AP: The Wnt/β-catenin pathway regulates growth and
maintenance of colonospheres. Mol Cancer. 9:2122010.
|
|
25
|
Hervieu V, Lepinasse F, Gouysse G, et al:
Expression of β-catenin in gastroenteropancreatic endocrine
tumours: a study of 229 cases. J Clin Pathol. 59:1300–1304.
2006.
|
|
26
|
Bianchi F, Hu J, Pelosi G, et al: Lung
cancers detected by screening with spiral computed tomography have
a malignant phenotype when analyzed by cDNA microarray. Clin Cancer
Res. 10:6023–6028. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang N, Zhang J, Shuai L, et al:
Krüppel-like factor 4 negatively regulates β-catenin expression and
inhibits the proliferation, invasion and metastasis of gastric
cancer. Int J Oncol. 40:2038–2048. 2012.
|
|
28
|
Lin SY, Xia W, Wang JC, et al: β-Catenin,
a novel prognostic marker for breast cancer: its roles in cyclin D1
expression and cancer progression. Proc Natl Acad Sci USA.
97:4262–4266. 2000.
|
|
29
|
Wong SC, Lo ES, Lee KC, Chan JK and Hsiao
WL: Prognostic and diagnostic significance of β-catenin nuclear
immunostaining in colorectal cancer. Clin Cancer Res. 10:1401–1408.
2004.
|
|
30
|
Duan Y, Liao AP, Kuppireddi S, Ye Z,
Ciancio MJ and Sun J: β-Catenin activity negatively regulates
bacteria-induced inflammation. Lab Invest. 87:613–624. 2007.
|
